Physicians' Academy for Cardiovascular Education

Integrating icosapent ethyl in cardiovascular risk reduction strategies: Practical guidance

10' education - Oct. 16, 2023 - Pam Taub, MD - La Jolla, CA, USA

Video navigation menu

  • Residual cardiovascular risk 01:01
  • CVD reduction with EPA 03:45
  • Case presentation 05:51
  • Summary 09:02


Show transcript

Educational information

This lecture by Pam Taub, MD was part of the EBAC-accredited symposium "Improving the management of patients with atherosclerotic cardiovascular disease - The evolving role of icosapent ethyl" at the ESC congress 2023.


Pam Taub is a board-certified cardiologist. She is the founding director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center and Professor of Medicine at UC San Diego.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Amarin.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: